However, the combination of NextA and anti-CD47 significantly decreased tumor growth, increased immune cell infiltration in the tumor microenvironment (TME), and modulated innate antitumor immunity, especially macrophage and natural killer (NK) cell populations. Here, CD47 is linked to neoplasm.